Family Office Briefing on research byCushman & Wakefield·Nov 10, 2023
Q3 2023 Raleigh Life Sciences Report
Raleigh life sciences market trends in Q3 2023 — family offices should consider co-GP opportunities with established operators.
Quantitative metrics for this report are published by Cushman & Wakefield in the full report. Read it directly below for the underlying data tables.
Full report
Cushman & Wakefield
Building a thesis around Raleigh? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.